title: Orbital metastasis as the initial presentation in bilateral lobular invasive carcinoma of the breast.
authors: *Department of Ophthalmology, Maimonides Medical Center, Brooklyn, New York, U.S.A.; †Department of Ophthalmology, Maimonides Medical Center, Brooklyn, New York, U.S.A.; ‡Department of Pathology, Staten Island University Hospital, Staten Island, New York, U.S.A.; §Maimonides Medical Center, SUNY Downstate Medical Center, and M-B CCOP; ‖Maimonides Cancer Center and Department of Radiation Oncology, Maimonides Medical Center, Brooklyn, New York, U.S.A.; and ¶Department of Surgery, Maimonides Medical Center and Maimonides Breast Cancer Center, Brooklyn, New York, U.S.A.
authors: Norman
authors: N
authors: Saffra
authors: Aleksandr
authors: A
authors: Rakhamimov
authors: Monika A
authors: MA
authors: Wrzolek
authors: William B
authors: WB
authors: Solomon
authors: Jay
authors: J
authors: Cooper
authors: Patrick
authors: P
authors: Borgen
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000473:pathology*; D018275:Carcinoma, Lobular / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D005260:Female; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009918:Orbital Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D013629:Tamoxifen / Q000627:therapeutic use; D014792:Visual Acuity
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D016729:Leuprolide